(SPB) Spectrum Brands Holdings - Overview
Stock: Appliances, Pet-Care, Garden, Pest-Control, Cleaning
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.08% |
| Yield on Cost 5y | 3.17% |
| Yield CAGR 5y | 2.85% |
| Payout Consistency | 41.9% |
| Payout Ratio | 33.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.8% |
| Relative Tail Risk | -7.02% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.14 |
| Alpha | -19.56 |
| Character TTM | |
|---|---|
| Beta | 0.839 |
| Beta Downside | 0.845 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.30% |
| CAGR/Max DD | 0.18 |
Description: SPB Spectrum Brands Holdings January 15, 2026
Spectrum Brands Holdings (NYSE:SPB) is a diversified consumer-products company operating in North America, Europe, the Middle East, Africa, Latin America, and Asia-Pacific. It is organized into three segments: Home and Personal Care (HPC), which sells appliances under brands such as Black & Decker and Remington; Global Pet Care (GPC), the largest driver of earnings, offering pet food and accessories under IAMS, Eukanuba, and Tetra; and Home & Garden (H&G), providing pest-control, lawn-care, and cleaning solutions under Spectracide, Hot Shot, and Cutter.
In FY 2023 the company generated roughly $3.2 billion in revenue, with the GPC segment contributing about 45 % of total sales and posting a 6 % year-over-year growth rate. Adjusted EBITDA margin hovered near 12 %, driven by steady pricing power in pet nutrition and incremental cost efficiencies in the HPC and H&G businesses. The global pet-care market is estimated at $110 billion and is expected to expand at a 5 % CAGR through 2028, providing a favorable tailwind for SPB’s pet-care franchise.
Key macro drivers include persistent inflation that squeezes discretionary spending on non-essential home appliances, while the DIY home-improvement trend and higher pet-ownership rates (now exceeding 70 % of U.S. households) support demand for SPB’s core product lines. Supply-chain disruptions remain a risk, particularly for raw material inputs in the pet-food segment, but the company’s diversified geographic footprint helps mitigate regional shocks.
For a deeper dive into SPB’s valuation metrics, see the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 99.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.80 > 1.0 |
| NWC/Revenue: 23.53% < 20% (prev 30.08%; Δ -6.55% < -1%) |
| CFO/TA 0.06 > 3% & CFO 203.6m > Net Income 99.9m |
| Net Debt (530.6m) to EBITDA (215.2m): 2.47 < 3 |
| Current Ratio: 2.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (24.3m) vs 12m ago -14.13% < -2% |
| Gross Margin: 36.74% > 18% (prev 0.37%; Δ 3636 % > 0.5%) |
| Asset Turnover: 77.79% > 50% (prev 77.14%; Δ 0.66% > 0%) |
| Interest Coverage Ratio: 3.91 > 6 (EBITDA TTM 215.2m / Interest Expense TTM 30.0m) |
Altman Z'' 5.23
| A: 0.20 (Total Current Assets 1.18b - Total Current Liabilities 523.2m) / Total Assets 3.38b |
| B: 0.66 (Retained Earnings 2.22b / Total Assets 3.38b) |
| C: 0.03 (EBIT TTM 117.2m / Avg Total Assets 3.61b) |
| D: 1.51 (Book Value of Equity 2.22b / Total Liabilities 1.47b) |
| Altman-Z'' Score: 5.23 = AAA |
Beneish M -3.13
| DSRI: 0.86 (Receivables 572.6m/706.1m, Revenue 2.81b/2.96b) |
| GMI: 1.02 (GM 36.74% / 37.42%) |
| AQI: 1.12 (AQ_t 0.55 / AQ_t-1 0.49) |
| SGI: 0.95 (Revenue 2.81b / 2.96b) |
| TATA: -0.03 (NI 99.9m - CFO 203.6m) / TA 3.38b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of SPB shares?
Over the past week, the price has changed by +18.85%, over one month by +21.17%, over three months by +39.39% and over the past year by +2.11%.
Is SPB a buy, sell or hold?
- StrongBuy: 4
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SPB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.7 | 2.6% |
| Analysts Target Price | 77.7 | 2.6% |
| ValueRay Target Price | 84.7 | 11.9% |
SPB Fundamental Data Overview January 31, 2026
P/E Forward = 13.6986
P/S = 0.5284
P/B = 0.7778
P/EG = 2.02
Revenue TTM = 2.81b USD
EBIT TTM = 117.2m USD
EBITDA TTM = 215.2m USD
Long Term Debt = 556.2m USD (from longTermDebt, last quarter)
Short Term Debt = 43.5m USD (from shortTermDebt, last quarter)
Debt = 654.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 530.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.01b USD (1.48b + Debt 654.2m - CCE 123.6m)
Interest Coverage Ratio = 3.91 (Ebit TTM 117.2m / Interest Expense TTM 30.0m)
EV/FCF = 12.19x (Enterprise Value 2.01b / FCF TTM 165.3m)
FCF Yield = 8.20% (FCF TTM 165.3m / Enterprise Value 2.01b)
FCF Margin = 5.88% (FCF TTM 165.3m / Revenue TTM 2.81b)
Net Margin = 3.56% (Net Income TTM 99.9m / Revenue TTM 2.81b)
Gross Margin = 36.74% ((Revenue TTM 2.81b - Cost of Revenue TTM 1.78b) / Revenue TTM)
Gross Margin QoQ = 34.98% (prev 37.75%)
Tobins Q-Ratio = 0.60 (Enterprise Value 2.01b / Total Assets 3.38b)
Interest Expense / Debt = 1.21% (Interest Expense 7.90m / Debt 654.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 92.6m (EBIT 117.2m * (1 - 21.00%))
Current Ratio = 2.26 (Total Current Assets 1.18b / Total Current Liabilities 523.2m)
Debt / Equity = 0.34 (Debt 654.2m / totalStockholderEquity, last quarter 1.91b)
Debt / EBITDA = 2.47 (Net Debt 530.6m / EBITDA 215.2m)
Debt / FCF = 3.21 (Net Debt 530.6m / FCF TTM 165.3m)
Total Stockholder Equity = 1.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.77% (Net Income 99.9m / Total Assets 3.38b)
RoE = 5.18% (Net Income TTM 99.9m / Total Stockholder Equity 1.93b)
RoCE = 4.72% (EBIT 117.2m / Capital Employed (Equity 1.93b + L.T.Debt 556.2m))
RoIC = 3.65% (NOPAT 92.6m / Invested Capital 2.54b)
WACC = 6.55% (E(1.48b)/V(2.14b) * Re(9.01%) + D(654.2m)/V(2.14b) * Rd(1.21%) * (1-Tc(0.21)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -15.58%
[DCF Debug] Terminal Value 77.35% ; FCFF base≈146.6m ; Y1≈96.2m ; Y5≈43.9m
Fair Price DCF = 27.34 (EV 1.17b - Net Debt 530.6m = Equity 636.5m / Shares 23.3m; r=6.55% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 43.22 | EPS CAGR: -17.25% | SUE: -1.17 | # QB: 0
Revenue Correlation: -55.28 | Revenue CAGR: -0.84% | SUE: -0.20 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.14 | Chg30d=+0.026 | Revisions Net=+1 | Analysts=7
EPS current Year (2026-09-30): EPS=4.44 | Chg30d=+0.013 | Revisions Net=+1 | Growth EPS=-18.2% | Growth Revenue=+0.5%
EPS next Year (2027-09-30): EPS=5.01 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=+12.7% | Growth Revenue=+1.5%